Medicinal Chemist Develops Imaging Tools to Target Degenerative Diseases

Neurodegenerative diseases, such as Alzheimer's and Parkinson's, affect more than 6.4 million Americans, according to the Harvard NeuroDiscovery Center. That number may double in the next 30 years as the population ages, unless medical researchers figure out what's happening at a cellular and molecular level and develop ways to treat or prevent these debilitating conditions.

Written bySouth Dakota State University
| 3 min read
Register for free to listen to this article
Listen with Speechify
0:00
3:00

Aging and oxidative stress are the culprits, but the challenge is to determine which cells, and even subcellular structures, are affected, according to South Dakota State University pharmacy professor Xiangming Guan. The medicinal chemist is developing imaging techniques that will help researchers identify what might be contributing to the course a degenerative disease takes.

Tracking the body's natural antioxidant

Organic molecules called thiols play a major role in defending the body against oxidative stress, Guan explained. These antioxidants, which are present inside and outside of cells, counteract the effect of reactive oxygen molecules known as free radicals which are involved in oxidative stress. Free radicals can disrupt normal cell functions.

"Thiols are consumed during oxidative stress, so we see lower thiol levels," Guan said. "Therefore, the level of thiols is used as one of the indices that reflect whether there is oxidative stress."

To continue reading this article, sign up for FREE to
Lab Manager Logo
Membership is FREE and provides you with instant access to eNewsletters, digital publications, article archives, and more.

CURRENT ISSUE - October 2025

Turning Safety Principles Into Daily Practice

Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature

Lab Manager October 2025 Cover Image